Senior insider sale
Chief Operating Officer at ENTRADA THERAPEUTICS, INC. — senior position signals high conviction
$438.1K
36.27K shares
What this filing means
DOWDEN NATHAN J plans to sell 36.27K shares of ENTRADA THERAPEUTICS, INC. valued at approximately $438.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/9/2026ACC: 0001950047-26-002366
Officer· Chief Operating Officer
Since Oct 2021
36.27K
Shares to sell
$438.1K
Approx. market value
15.01K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/1/2024
15.01KTotal acquired15.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2024 | Restricted Stock Units N/A | 15.01K | — |
| Total | 15.01K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
14.04K
Market value
$165.0K
3/3/2026
—Completed
Units to sell
7.22K
Market value
$84.2K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
15.01K
Market value
$188.8K
3/9/2026
Total
Units
36.27K
Value
$438.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 14.04K | $165.0K | — | Completed |
3/2/2026 | 7.22K | $84.2K | — | Completed |
| Planned — Approximate Date | ||||
3/9/2026 | 15.01K | $188.8K | NASDAQ | Planned |
| Total | 36.27K | $438.1K | ||